Sanofi Cuts 466 Jobs, Limits Cardiovascular and Diabetes R&D | GEN - Genetic Engineering & Biotechnology News
Sanofi Cuts 466 Jobs, Limits Cardiovascular and Diabetes R&D | GEN Genetic Engineering & Biotechnology NewsSanofi will eliminate 466 jobs in France and Germany, as well as end new in-house cardiology research programs, in a restructuring of its global R&D.